Tag: aspiration thrombectomy
The physics of aspiration thrombectomy—what matters?
This advertorial, intended for readers outside the USA only, is sponsored by Penumbra.
Much of the clinical success that can be achieved with aspiration-based mechanical...
Imperative announces late-breaking data showing benefits of ‘angled-tip’ aspiration catheters
Imperative Care has announced late-breaking data from the Neurovascular Quality Initiative-Quality Outcome Database (NVQI-QOD) evaluating its Zoom stroke solution, which were presented at the...
“No significant difference” between aspiration and stent-retriever thrombectomy in medium vessel...
When utilised as a first-line technique for medium vessel occlusion (MeVO) stroke, aspiration and stent-retriever thrombectomy have demonstrated “no significant difference” in imaging-related or...
Combined thrombectomy technique fails to demonstrate superiority over aspiration alone
New data from the VECTOR randomised controlled trial—presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany)—have indicated that a mechanical thrombectomy...
Paediatric case helps highlight benefit of ‘aspiration first’ in young stroke...
A unique case presentation at this year’s LINNC Americas Seminar (16–17 March, Miami, USA) saw Rafael de Oliveira Sillero (University of Texas Southwestern Medical...
US physicians publish “first reported use” of Indigo aspiration system for...
Physicians in the USA have published details of—to their knowledge—the “first reported use” of the Indigo aspiration system (Penumbra) to treat cerebral venous sinus...
Route 92 publishes data demonstrating 80% first-pass effect with novel thrombectomy...
Route 92 Medical has announced the publication of initial results from the SUMMIT NZ clinical trial—a single-arm, multicentre, prospective trial evaluating its proprietary Monopoint...
Penumbra receives FDA clearance for RED 62 reperfusion catheter
Penumbra has announced US Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED 62 reperfusion catheter—the latest addition to the...
HeMo Bioengineering receives China’s NMPA approval for Afentta aspiration catheter
HeMo Bioengineering, a Singapore-based medical device company with a focus on treating stroke patients, has announced that its Afentta intracranial thrombectomy aspiration catheter—a product...
Clot permeability linked to first-attempt success of aspiration thrombectomy
A multicentre study has reported that clot perviousness or permeability, the ability for contrast used during the initial imaging workup to seep through a...
